BUSINESS
COVID-19 treatment | Gilead signs pact with Cipla, Jubilant and Hetero to manufacture, distribute Remdesivir in 127 countries
The licenses are royalty-free until the World Health Organization (WHO) declares the end of the Public Health Emergency of International Concern regarding COVID-19, or until a pharmaceutical product other than remdesivir or a vaccine is approved to treat or prevent COVID-19, whichever is earlier.
BUSINESS
Explainer: What is ELISA test, will it help us scale up COVID-19 surveillance efforts?
The ICMR will be soon deploying ELISA testing for conducting a national-level surveillance study on the prevalence of COVID-19.
BUSINESS
Liquidity a big challenge, expect economic recovery to take 2-3 quarters: Ajay Piramal
"It will take at least two or three quarters to reach the December 2019 GDP level of 4.7 percent. This crisis is going to impact all industries, with liquidity being one of the big challenges," Piramal said in the post earnings media call.
BUSINESS
COVID-19 treatment: Jaipur's SMS Medical College says plasma therapy shows promise
SMS medical team members to submit data to ICMR once they complete plasma therapy on 20 patients.
BUSINESS
Gurgaon-based Premas Biotech enters COVID-19 vaccine race with triple antigen vaccine
The multi-antigenic approach is being designed to try to overcome presently known and possible future mutations of novel coronavirus, which, if successful, would result in the development of an effective vaccine, the company said.
BUSINESS
Patients bear the brunt as mandatory COVID-19 charges inflate hospital bills but insurers shy away
Hospitals are passing on the costs of controlling infection spread due to COVID-19 on the customers.
BUSINESS
In race to get COVID-19 vaccine, are we setting the bar low?
More than 30 vaccines are currently in various stages of development in India and a few are expected to hit human trials in the next few months.
BUSINESS
Govt's CSIR lab completes synthesis of Gilead's drug Remdesivir KSMs for coronavirus
KSM or intermediate, are raw materials used in the production of a drug
BUSINESS
Abbott to bring COVID-19 antibody test to India by May-end
Abbott received CE mark approval this week for its laboratory-based serology blood (antibody) test for the detection of the antibody, IgG, that identifies if a person has had the COVID-19.
BUSINESS
Exclusive: Gilead says open to collaborate with govts, drug firms to make Remdesivir globally available
There is a possibility of Indian companies becoming part of the consortium, in the past Gilead used voluntary licenses to rope in Indian cos to manufacture and launch HIV and hepatitis-C medications in low-middle-income countries (LMICs).
BUSINESS
Furore over rapid antibody test kits: Here's all you need to know
So far, India has tested about 8.3 lakh samples for a population of more than 1.3 billion, which translates to about testing of 602 people for 1 million population.
BUSINESS
COVID-19 impact | Here's why a visit to your dentist after lockdown may pinch you harder
Analysts estimate that at least 20 percent of the dental clinics may have to be shuttered if the current situation persists beyond May.
BUSINESS
COVID-19 pandemic: These 3D printing companies are helping India fix shortage of face shields, ventilators
Indian research institutions and companies have started banking on 3D printing as a quick fix.
INDIA
Why it is important to tackle social stigma as we fight COVID-19
Stigma can undermine social cohesion and prompt possible social isolation of groups, which might contribute to a situation where the virus is more, not less, likely to spread.
BUSINESS
From cleaning floors to keeping patients' company, these robots are helping doctors fight coronavirus
Around 10 robots of Milagrow are already in operation in several hospitals in Delhi NCR including Indraprastha Apollo Hospitals and Fortis Memorial Research Institute.
BUSINESS
Why RT-PCR COVID-19 test can be cheaper than the Rs 4,500 ICMR price cap
Moneycontrol learns that this was possible due to easing supply position and drop in prices of RT-PCR test kits that constitutes about one-third of a COVID-19 test
BUSINESS
Trivitron Healthcare to roll out locally-built ventilator in May
Around 300-400 engineers and other technical staff are working 24x7 at Trivitron's factories in Andhra Pradesh Medtech Zone (AMTZ), Vizag and Chennai.
BUSINESS
Cadila Healthcare says exploring cancer, hepatitis drug Interferon alpha-2b for COVID-19
The Ahmedabad-based drug maker said it is ready to undertake clinical trials based on government's response.
BUSINESS
Wockhardt's novel antibiotic WCK6777 gets fast-track status from USFDA
WCK 6777 is used in the treatment of complicated urinary tract infections and intra-abdominal infections.
BUSINESS
Pharma wrap: Why the rise in cured COVID-19 people raises hope
According to Ministry of Health and Family Welfare (MoHFW), India has so far 12974 active cases, 2230 were cured or discharged and 507 deaths.
BUSINESS
Overcoming all COVID-19 odds, this pharma company delivered life-saving medicine to patients
Yugal Sikri, Managing Director, RPG Life Sciences narrated the unprecedented chaos and disruption his company has to go through to bring a life-saving medication Azathioprine to patients in India.
BUSINESS
Coronavirus testing | Private labs in Karnataka to conduct tests for govt at half the price
"Based on the discussions and negotiations, the cost per test has been fixed at Rs 2,250," the Karnataka government said.
BUSINESS
Coronavirus impact | Hospitals feel the pinch of infection control measures
Hospitals said that the insurance companies are not covering the additional costs.
BUSINESS
How little known Mylab became a frontrunner in India's fight against COVID-19
Mylab says it is ramping up capacity and can produce up to 20 lakh test kits per week in a month's time.
